ICH Considerations: general principles to address virus and vector shedding

  • Email
  • Help
Current version

ICH Considerations

Reference numberEMEA/CHMP/ICH/449035/2009
Published01/07/2009
KeywordsGene therapy medicinal products, gene therapy, shedding, analytical assays, non-clinical, clinical
DescriptionThis document provides recommendations for designing non-clinical and clinical virus/vector shedding studies. In particular, it emphasizes the analytical assays used for detection and considerations for the sampling profiles and schedules in both non-clinical and clinical studies. The interpretation of non-clinical data and its use in designing clinical studies is also within the scope of this paper, as well as the interpretation of clinical data in assessing the need for virus/vector transmission studies.


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more